EMPLOYMENT AGREEMENTEmployment Agreement • November 4th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 4th, 2016 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made and entered into as of this 21st day of September, 2016, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Remi Menes (the “Employee”).
SIXTH AMENDMENT TO FORBEARANCE AGREEMENTForbearance Agreement • November 4th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 4th, 2016 Company IndustryTHIS SIXTH AMENDMENT TO FORBEARANCE AGREEMENT (this “Amendment”) is made as of this 30th day of September, 2016 by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AEGERION PHARMACEUTICALS, INC., a Delaware corporation with its chief executive office located at One Main Street, 8th Floor, Cambridge, Massachusetts 02142 (“Borrower”).
FIFTH AMENDMENT TO LEASELease • November 4th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 4th, 2016 Company IndustryTHIS FIFTH AMENDMENT TO LEASE, dated as of July 19, 2016 (this “Amendment”), between RREEF AMERICA REIT II CORP. PPP, a Maryland corporation (“Landlord”), and AEGERION PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”), for certain premises located in two buildings in Riverfront Office Park, Cambridge, Massachusetts at 101 Main Street (the “101 Main Building”) and One Main Street (the “One Main Building” and, collectively with the 101 Main Building, the “Building”).